Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhimin Shao

Showing results (121-130 of 203) with videos related to

Pageof 21
Sort By:
BMC Cancer|October 23, 2009
Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 monthsOu Huang, Canming Chen, Jiayi Wu, et al.
Applied and Environmental Microbiology|October 29, 2017
Divergent Responses of Forest Soil Microbial Communities under Elevated CO<sub>2</sub> in Different Depths of Upper Soil LayersHao Yu, Zhili He, Aijie Wang, et al.
Cancer Medicine|May 22, 2022
Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgeryYilan Yang, Xu Zhao, Xuanyi Wang, et al.
Journal of Breast Cancer|October 3, 2018
Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with <i>BRCA1/2</i> MutationsXinyi Zhu, Tian Tian, Miao Ruan, et al.
Cell Discovery|September 16, 2024
Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancerWenxiao Yang, Luo Hong, Linwei Guo, et al.
Cancer Chemotherapy and Pharmacology|October 13, 2010
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trialBinghe Xu, Zefei Jiang, Zhimin Shao, et al.
Breast Cancer Research and Treatment|October 1, 2010
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significanceXinmin Zhao, Xiaofeng Xu, Lin Guo, et al.
Breast Cancer Research and Treatment|September 7, 2021
Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?Xiaofang Wang, Li Zhang, Xiaomeng Zhang, et al.
Oncology and Therapy|October 26, 2025
Real-World Epidemiology, Clinical Characteristics and Outcomes of Women with Germline BRCA Mutation and Early Breast Cancer in ChinaZhen Hu, Qianqian Yu, Liqin Chen, et al.
Breast Cancer (Tokyo, Japan)|October 23, 2024
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation fieldXiaofang Wang, Xiaomeng Zhang, Li Zhang, et al.
Pageof 21

Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
BMC Cancer|October 23, 2009
Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 monthsOu Huang, Canming Chen, Jiayi Wu, et al.
Applied and Environmental Microbiology|October 29, 2017
Divergent Responses of Forest Soil Microbial Communities under Elevated CO<sub>2</sub> in Different Depths of Upper Soil LayersHao Yu, Zhili He, Aijie Wang, et al.
Cancer Medicine|May 22, 2022
Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgeryYilan Yang, Xu Zhao, Xuanyi Wang, et al.
Journal of Breast Cancer|October 3, 2018
Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with <i>BRCA1/2</i> MutationsXinyi Zhu, Tian Tian, Miao Ruan, et al.
Cell Discovery|September 16, 2024
Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancerWenxiao Yang, Luo Hong, Linwei Guo, et al.
Cancer Chemotherapy and Pharmacology|October 13, 2010
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trialBinghe Xu, Zefei Jiang, Zhimin Shao, et al.
Breast Cancer Research and Treatment|October 1, 2010
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significanceXinmin Zhao, Xiaofeng Xu, Lin Guo, et al.
Breast Cancer Research and Treatment|September 7, 2021
Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?Xiaofang Wang, Li Zhang, Xiaomeng Zhang, et al.
Oncology and Therapy|October 26, 2025
Real-World Epidemiology, Clinical Characteristics and Outcomes of Women with Germline BRCA Mutation and Early Breast Cancer in ChinaZhen Hu, Qianqian Yu, Liqin Chen, et al.
Breast Cancer (Tokyo, Japan)|October 23, 2024
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation fieldXiaofang Wang, Xiaomeng Zhang, Li Zhang, et al.
Pageof 21